Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2021-04-23 Regulatory Filings
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
6-K Filing
Regulatory Filings
2021-04-23 English
Extension of lock-up period in Gilead-Galapagos collaboration agreement
Regulatory Filings Classification · 95% confidence The document is a press release announcing an amendment to a share subscription agreement between Gilead and Galapagos, specifically extending a lock-up period for Gilead's shareholding. This type of corporate announcement regarding capital structure, shareholding agreements, and strategic partnerships falls under the category of 'Capital/Financing Update' (CAP). It is not a report publication announcement (RPA) as it provides the substantive details of the agreement rather than just announcing the availability of a report.
2021-04-09 English
Extension of lock-up period in Gilead-Galapagos collaboration agreement
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated April 8, 2021, announcing an amendment to a collaboration agreement between Gilead and Galapagos, specifically extending a lock-up period for Gilead's shareholding. This announcement concerns a significant corporate action related to ownership structure and partnership terms, but it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV). It is an announcement detailing a change in capital structure/ownership commitment, which aligns closely with 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if it were a mandatory disclosure. Given the focus on the share subscription agreement amendment and the resulting lock-up extension affecting ownership percentage, 'Capital/Financing Update' (CAP) is the most appropriate fit, as it deals with the terms governing equity holdings and financing arrangements between the two entities. It is not a general M&A (TAR) as it is an amendment to an existing agreement, nor is it a Director's Dealing (DIRS). Since it is a specific corporate action announcement, CAP is preferred over the general RNS fallback.
2021-04-09 English
6-K Filing
Regulatory Filings
2021-04-09 English
Publication of the annual report and invitation to the ordinary shareholders’ meeting
AGM Information Classification · 95% confidence The document is titled "Publication of the annual report and invitation to the ordinary shareholders' meeting" and explicitly states that Galapagos NV "published its annual report for the financial year 2020." It also mentions the availability of the Form 20-F (a type of 10-K filing) and provides an invitation and agenda for the upcoming ordinary shareholders' meeting. Since the document's primary purpose is to announce the publication of the Annual Report (10-K) and the AGM details, it functions as a Report Publication Announcement (RPA) or a combined announcement. However, because it heavily features the invitation and agenda for the shareholders' meeting, and the AGM invitation is a key component, AGM-R is a strong candidate. Given the explicit mention of publishing the 'annual report' and the invitation to the 'ordinary shareholders' meeting' in the same release, this is a hybrid announcement. The presence of the AGM invitation and agenda (reappointments, voting procedures) strongly points towards AGM-R, which covers AGM materials. If the document were purely the 10-K, it would be classified as 10-K. Since it is an announcement *about* the report publication AND the AGM invitation, and AGM-R covers AGM materials, this is the most fitting specific category for the meeting announcement aspect, although RPA is also plausible for the report announcement part. Given the detailed AGM logistics, AGM-R is selected over RPA.
2021-03-26 English
6-K Filing
Regulatory Filings
2021-03-26 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.